Zobrazeno 101 - 110
of 518
pro vyhledávání: '"Pär Stattin"'
Autor:
Kerri, Beckmann, Hans, Garmo, Per, Nilsson, Ingela, Franck Lissbrant, Anders, Widmark, Pär, Stattin
Publikováno v:
Acta oncologica (Stockholm, Sweden). 59(5)
Publikováno v:
The Journal of urology. 204(1)
We investigated whether men with biopsy verified, low grade cancer and a family history of lethal or advanced prostate cancer are at particularly high risk for harboring undetected high grade disease.Upgrading and up staging of prostate cancer are co
Publikováno v:
BJU internationalReferences. 125(5)
To investigate whether post-transplantation immunosuppression negatively affects prostate cancer outcomes in male kidney transplant recipients.We used the Swedish Renal Register and the National Prostate Cancer Register to identify all kidney transpl
Autor:
Jonathan Parker, Danielle Crawley, Hans Garmo, Bertil Lindahl, Johan Styrke, Jan Adolfsson, Mats Lambe, Pär Stattin, Mieke Van Hemelrijck, Kerri Beckmann
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology
Frontiers in Oncology
Refereed/Peer-reviewed Existing literature examining warfarin's association with prostate cancer (PCa) risk provides conflicting results, while the association with direct oral anticoagulants (DOACs) has not yet been studied. We investigated the asso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::962203a0e4dd6211cff296cfec072734
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-176488
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-176488
Autor:
Karl-Johan Lundström, Pär Stattin, Sven Resare, Christofer Lagerros, Patrick Masaba, Johan Styrke
Publikováno v:
F1000Research
Background: The risk of infection after transrectal ultrasound (TRUS)-guided prostate biopsies is increasing. The aim of the study was to assess the use of antibiotic prophylaxis for prostate biopsy in Sweden. Methods: All public and private urology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbc74f164e00a831e7cd373d218a85e4
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-177380
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-177380
Autor:
Giuseppe Fallara, Ingela Franck Lissbrant, Johan Styrke, Francesco Montorsi, Hans Garmo, Pär Stattin
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 12, p e0244462 (2020)
PLoS ONE, Vol 15, Iss 12, p e0244462 (2020)
IntroductionThe aim of this study was to assess time on treatment with abiraterone and enzalutamide, two androgen receptor targeted (ART) drugs, the impact on time on treatment of time interval without drug supply between prescription fillings, and a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::3c1d128386c326019f41f3fe02731336
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-433379
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-433379
Autor:
Ingela Franck Lissbrant, Marcus Westerberg, Pär Stattin, David Robinson, Hans Garmo, Andri Wilberg Orrason
Objective To evaluate whether the effects of radical treatment in men with locally advanced prostate cancer (PCa) on PCa mortality observed in randomised clinical trials are applicable on a population basis. Patients and methods We conducted a popula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04b7ce922efcd47fb9768ad970a5f885
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-423772
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-423772
Autor:
Montse Soriano Gabarró, Jihong Zong, Juha Mehtälä, Houssem Khanfir, Gunnar Brobert, Zdravko P. Vassilev, Pär Stattin
Publikováno v:
PLoS ONE, Vol 15, Iss 2, p e0227552 (2020)
PLoS ONE
PLoS ONE
Background Among prostate cancer (PC) patients, over 90% of distant metastases occur in the bone. PC treatments may be associated with side effects, including second primary malignancies (SPM). There is limited information on the incidence of SPM amo
Autor:
Bengt Järvholm, Sylvia H J Jochems, Tanja Stocks, Marju Orho-Melander, Christel Häggström, Pär Stattin, Angela M. Wood
Obesity is a risk factor for advanced, but not localised, prostate cancer (PCa), and for poor prognosis. However, the detection of localised PCa through asymptomatic screening might influence these associations. We investigated height and body mass i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c8d2d97ac12ddf9e930c0f1991eaad3
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-172173
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-172173
Autor:
Kerri, Beckmann, Hans, Garmo, Bertil, Lindahl, Lars, Holmberg, Pär, Stattin, Jan, Adolfsson, J Kennedy, Cruickshank, Mieke, Van Hemelrijck
Publikováno v:
Prostate cancer and prostatic diseases. 23(3)
Spironolactone, a cheap effective diuretic used to manage hypertension and heart failure, also has anti-androgenic effects through its non-selective binding to steroid receptors, and hence may affect prostate cancer (PCa) risk. This study investigate